Health Care & Life Sciences » Healthcare Provision | Bioanalytical Systems Inc.

Bioanalytical Systems Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
22,068.00
24,584.00
22,698.00
20,441.00
24,242.00
26,346
Cost of Goods Sold (COGS) incl. D&A
15,013.00
16,622.00
15,209.00
16,016.00
16,545.00
18,230
Gross Income
7,055.00
7,962.00
7,489.00
4,425.00
7,697.00
8,116
SG&A Expense
6,225.00
7,254.00
7,185.00
6,494.00
6,419.00
8,102
EBIT
830.00
708.00
304.00
-
1,278.00
14
Unusual Expense
601.00
1,292.00
1,092.00
782.00
-
-
Non Operating Income/Expense
7.00
9.00
5.00
6.00
5.00
6
Interest Expense
649.00
488.00
287.00
399.00
375.00
274
Pretax Income
789.00
1,063.00
1,114.00
3,244.00
908.00
254
Income Tax
16.00
7.00
15.00
14.00
24.00
60
Consolidated Net Income
773.00
1,070.00
1,099.00
3,230.00
884.00
194
Net Income
773.00
1,070.00
1,099.00
3,230.00
884.00
194
Net Income After Extraordinaries
773.00
1,070.00
1,099.00
3,230.00
884.00
194
Net Income Available to Common
773.00
1,070.00
1,099.00
3,230.00
884.00
194
EPS (Basic)
0.09
0.13
0.07
0.40
0.10
0.02
Basic Shares Outstanding
7,664.00
7,960.00
8,084.00
8,107.00
8,178.00
8,771
EPS (Diluted)
0.09
0.13
0.07
0.40
0.10
0.02
Diluted Shares Outstanding
8,371.00
7,960.00
8,791.00
8,107.00
8,733.00
8,771
EBITDA
2,553.00
2,305.00
1,713.00
513.00
2,958.00
1,870

About Bioanalytical Systems

View Profile
Address
2701 Kent Avenue
West Lafayette Indiana 47906
United States
Employees -
Website http://www.basinc.com
Updated 07/08/2019
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.